Vittal Hejjaji is a Cardiology physician affiliated with Mount Sinai Medical Center. OpenAlex indexes 63 publications with 440 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year202511 payments
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.9%Beta blocker20.2%Metoprolol Succinate51%Carvedilol32%Metoprolol Tartrate17%Part D≥38 patientsStatin14.1%Rosuvastatin Calcium53%Atorvastatin Calcium31%Pravastatin Sodium16%Part D<11 patients+ 8 more classes in this area
Blood & clotting
12.5%Factor Xa inhibitor9%Eliquis83%Xarelto17%Part D<11 patientsP2Y12 inhibitor3.5%Clopidogrel100%Part D≥13 patientsMetabolism & gastrointestinal
6.7%SGLT2 inhibitor6.7%Farxiga73%Jardiance27%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Disparities in the Use of Atherectomy and Intravascular Lithotripsy for Percutaneous Coronary Intervention
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - THE EFFECT OF PERSONAL PROTECTIVE AIDS ON HYPERTENSION AND DIABETES IN PEOPLE LIVING WITH HIGH LEVELS OF CHRONIC AIR POLLUTION: A RANDOMIZED CROSSOVER STUDY
American Journal of Preventive Cardiology
2025 - Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry
Circulation Cardiovascular Quality and Outcomes
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gervasio Lamas, MD
Mount Sinai Medical Center
Raul Weiss, MD
Mount Sinai Medical Center
John Chaloupka, MD
Mount Sinai Medical Center
Akshay Bhandari, MD
Mount Sinai Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”